What is the current Travel Vaccines market size?

The Travel Vaccines market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Travel Vaccines market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Travel Vaccines market?

Increasing travel demand and rising awareness of vaccine-preventable diseases drive the market.

What are the major challenges facing the Travel Vaccines market?

Limited vaccine availability and high development costs are significant challenges.

Which regions are leading the Travel Vaccines market?

North America and Europe are the leading regions due to high travel rates.

Who are the top companies in the Travel Vaccines market?

Sanofi, GlaxoSmithKline, and Merck are prominent players in the market.

What future opportunities exist in the Travel Vaccines market?

Emerging markets and innovative vaccine technologies offer growth opportunities.

How is technology impacting the Travel Vaccines market?

Advances in vaccine development and digital health platforms are transforming the market.

What is the current regulatory landscape for Travel Vaccines?

Stringent regulations and safety standards govern the market, ensuring vaccine efficacy.

What is the future outlook for the Travel Vaccines market?

The market is expected to experience steady growth, driven by increasing demand.

Travel Vaccines Size, Share & Forecast Analysis 2025–2033

Travel Vaccines by Application (Hospital, Clinic), by Types (Cholera, Rabies Vaccine, Hepatitis, Typhoid), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $12.6 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $12.6 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Travel Vaccines Market Size | CAGR 7.8 Forecast 2033

Travel Vaccines Size, Share & Forecast Analysis 2025–2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $12.6 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $12.6 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Travel Vaccines Market Overview

The Travel Vaccines market is a crucial segment of the global healthcare industry, playing a vital role in preventing the spread of infectious diseases among travelers. As the world becomes increasingly interconnected, the relevance of travel vaccines has grown significantly. The Travel Vaccines market size was approximately $2.8 billion in 2021 and is expected to reach $4.7 billion by 2026, with a growth outlook that is largely positive. The market forecast suggests a compound annual growth rate (CAGR) of around 8.5% during the forecast period, driven by factors such as increasing travel demand, advancements in vaccine technology, and rising awareness about infectious diseases. The industry expansion is also influenced by government initiatives and regulations, consumer behavior, and competitive intensity among market players.

Loading chart…

The Travel Vaccines market is shaped by several key forces, including technology shifts towards more effective and convenient vaccine formulations, regulations and guidelines set by health organizations, and consumer behavior driven by increasing awareness about travel health. The largest region in the Travel Vaccines market is currently North America, while the fastest-growing region is expected to be Asia-Pacific, driven by rising travel demand and improving healthcare infrastructure. As the market continues to evolve, it is essential for industry players to stay informed about the latest trends, challenges, and opportunities to maintain a competitive edge and drive business growth.

Report Overview

Report Attribute	Details
Market size value in 2025	12.60 million
Revenue forecast in 2033	22.98 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GSK; Sanofi; Merck; Pfizer; Jintan; CSL; MedImmune LLC; J&J(Crucell); China National Biotec; Tiantan; Hualan; Kangtai; Hissen
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Travel Vaccines market is poised for significant growth, driven by increasing international travel and rising awareness about vaccine-preventable diseases. Understanding the market dynamics is crucial for stakeholders to navigate the complex landscape and capitalize on emerging opportunities.

Growth Drivers2 items

Advances in vaccine technology and the development of new vaccines against emerging diseases are expected to drive the Travel Vaccines market size, with a growth forecast indicating a significant increase in demand over the next five years.

Government initiatives and recommendations for travel vaccinations, particularly in regions with high disease prevalence, are anticipated to boost the Travel Vaccines market, as more travelers seek vaccination to ensure a safe journey.

Restraints2 items

High development costs and stringent regulatory requirements for vaccine approval may hinder the growth of the Travel Vaccines market, as manufacturers face significant barriers to entry and product commercialization.

Vaccine hesitancy and misconceptions about vaccine safety may also restrain the Travel Vaccines market size, as some travelers may opt out of vaccinations due to concerns or misinformation.

Opportunities2 items

The expanding middle class in emerging economies and increasing international travel from these regions present opportunities for growth in the Travel Vaccines market, as more individuals seek travel vaccinations to protect against infectious diseases.

Public-private partnerships and collaborations between vaccine manufacturers, governments, and healthcare providers can facilitate the development and distribution of travel vaccines, driving market growth and improving access to vaccinations.

Challenges2 items

The Travel Vaccines market faces challenges related to supply chain logistics, including cold chain maintenance and vaccine distribution, particularly in resource-limited settings, which can impact vaccine efficacy and availability.

Competition from existing vaccines and therapies, as well as the potential for market disruption due to emerging technologies or innovative vaccine delivery systems, may also pose challenges for established players in the Travel Vaccines market.

Market Segmentation

Loading chart…

The Travel Vaccines segmentation by Application includes various categories that contribute to the overall market size. The primary applications of Travel Vaccines are for Hepatitis A, Hepatitis B, Typhoid, Rabies, and Meningococcal disease. Each of these applications has a significant share in the market, with Hepatitis A and Hepatitis B being the most prominent. The application segment is crucial in understanding the market taxonomy as it helps in identifying the specific vaccine requirements for different destinations and types of travel.

The Types segment of the Travel Vaccines market includes Inactivated Vaccines, Live Attenuated Vaccines, Conjugate Vaccines, Subunit Vaccines, and Toxoid Vaccines. Inactivated Vaccines and Live Attenuated Vaccines are the most commonly used types, accounting for a significant share of the market. The types of vaccines used vary based on the disease, the age of the traveler, and the destination. Understanding the types of vaccines is essential for Travel Vaccines market analysis as it helps in assessing the vaccine preferences and requirements of travelers.

Travel Vaccines Segmentation Breakdown8 items

Application

Hospital

Clinic

Types

Cholera

Rabies Vaccine

Hepatitis

Typhoid

Regional Insights

Loading chart…

The Travel Vaccines market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market, and Latin America being the fastest-growing region. Key drivers for North America include high adoption rates, strong infrastructure, and significant investments in research and development. In Europe, factors such as favorable policies, a mature ecosystem, and a large demographics contribute to the region's growth.

In Asia Pacific, the growing middle class, increasing tourism, and government initiatives drive the demand for travel vaccines. Latin America is experiencing rapid growth due to improving healthcare infrastructure, rising awareness about travel vaccines, and increasing foreign travel. The Middle East & Africa region is driven by government investments in healthcare, a growing expat population, and rising tourism.

Regional Drivers5 items

North America: high adoption rates, strong infrastructure, significant investments

Europe: favorable policies, mature ecosystem, large demographics

Asia Pacific: growing middle class, increasing tourism, government initiatives

Latin America: improving healthcare infrastructure, rising awareness, increasing foreign travel

Middle East & Africa: government investments in healthcare, growing expat population, rising tourism

Competitive Landscape

The Travel Vaccines market is moderately consolidated, with a mix of global players and local/regional companies competing on various levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Travel Vaccines competitive landscape is characterized by high competition, with key players employing different strategies to gain market share. Global players such as GSK and Sanofi have a strong presence, while local companies like Jintan and China National Biotec also play a significant role.

Companies in the Travel Vaccines market adopt various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Common differentiation factors include technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. The following companies have adopted specific strategic focuses:

GSK: regional expansion

Sanofi: premium pricing

Merck: innovation pipeline

Pfizer: local manufacturing

J&J(Crucell): OEM tie-ups

China National Biotec: vertical integration

Key Travel Vaccines Companies13 items

GSK

Sanofi

Merck

Pfizer

Jintan

CSL

MedImmune LLC

J&J(Crucell)

China National Biotec

Tiantan

Hualan

Kangtai

Hissen

Market Ecosystem

The Travel Vaccines ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. This complex network creates and captures value through the development, manufacturing, and distribution of vaccines to prevent infectious diseases contracted during travel. The ecosystem boundaries are defined by the interactions among these participants, influencing the overall efficiency and effectiveness of the Travel Vaccines value chain analysis.

Raw material suppliers — providing vaccine components

OEMs / manufacturers — producing travel vaccines

Distributors / channel partners — delivering vaccines to healthcare providers

Service providers / after-sales — offering vaccination services and support

End users / buyers — travelers and healthcare organizations

Regulators/standards bodies — overseeing vaccine approvals and compliance

Data/analytics providers — tracking vaccine efficacy and disease outbreaks

The flow of value in the Travel Vaccines ecosystem is influenced by control points, such as regulatory approvals and disease outbreak tracking, which can create bottlenecks and impact vaccine adoption. Dependency risks, including input constraints and standards compliance, can also affect the ecosystem's efficiency. Furthermore, switching costs, partnerships, and interoperability requirements can vary by region, leading to differences in the Travel Vaccines ecosystem across diverse areas.

Recent Industry Insights

The Travel Vaccines industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between pharmaceutical companies and research institutions have led to the development of new vaccine candidates. Additionally, there have been notable mergers and acquisitions, such as the acquisition of smaller biotech firms by larger pharmaceutical companies, which has expanded their product portfolios and enhanced their research capabilities.

Furthermore, several product launches have taken place, including the introduction of new vaccine formulations and administration methods. Regulatory changes, such as the approval of new vaccines by regulatory authorities, have also impacted the market. A shift in consumer trends towards increased awareness of travel health has driven demand for travel vaccines, while enterprises have expanded their offerings to cater to this growing demand. Funding rounds and expansions have also been observed, with companies investing in research and development to stay ahead in the market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Travel Vaccines market outlook, highlighting its attractiveness and competitive intensity. The market exhibits a moderate level of attractiveness, driven by increasing travel demand and growing awareness of vaccine-preventable diseases. The competitive landscape is intense, with several key players vying for market share.

The long-term outlook for the Travel Vaccines market is positive, with innovation in vaccine development and distribution expected to drive growth. However, the market is not without risks, including supply chain disruptions and regulatory challenges. Despite these risks, the demand-supply balance is expected to remain stable, with manufacturers working to meet increasing demand for travel vaccines. Key risk factors include global health crises and economic downturns, which can impact travel demand and vaccine sales.

12 items

1. Executive Summary

2. Travel Vaccines Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Travel Vaccines Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Travel Vaccines Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Travel Vaccines Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Travel Vaccines Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Travel Vaccines Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Travel Vaccines Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Travel Vaccines Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Travel Vaccines Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Travel Vaccines Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Travel Vaccines Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Travel Vaccines Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Travel Vaccines Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Travel Vaccines Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Travel Vaccines Market Competition by Key Manufacturers

9.1. Global Travel Vaccines Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Travel Vaccines: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. GSK

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Sanofi

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Merck

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Pfizer

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Jintan

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. CSL

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. MedImmune LLC

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. J&J(Crucell)

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. China National Biotec

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Tiantan

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Hualan

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Kangtai

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Hissen

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Travel Vaccines Market

Figure 4: Global Travel Vaccines Market: Drivers

Figure 5: Global Travel Vaccines Market: Challenges

Figure 6: Global Travel Vaccines Market: Trends

Figure 7: Global Travel Vaccines Market: Opportunity

Figure 8: Global Travel Vaccines Market: Restraint

Figure 9: Global Travel Vaccines Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Travel Vaccines Market Value (USD Million) By Region

Figure 19: Global Travel Vaccines Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Travel Vaccines Market Value (USD Million) By Region

Figure 27: Global Travel Vaccines Market Share (%) By: Regions (2032)

Figure 28: Global Travel Vaccines Market Volume (K) By Region

Figure 29: Global Travel Vaccines Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Travel Vaccines Market Value (USD Million) By Region

Figure 37: Global Travel Vaccines Market Share (%) By: Regions (2032)

Figure 38: Global Travel Vaccines Market Volume (K) By Region

Figure 39: Global Travel Vaccines Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

121 items

Table 1: Market Segmentation Analysis

Table 2: Global Travel Vaccines Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Travel Vaccines Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Travel Vaccines Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Travel Vaccines Market Value (USD Million) By Region

Table 14: Global Travel Vaccines Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Travel Vaccines Market Volume (K) By Region

Table 31: Global Travel Vaccines Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Travel Vaccines Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Travel Vaccines Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Travel Vaccines Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: GSK Basic Information And Sales Area

Table 52: GSK. Products Portfolio

Table 53: Sanofi Basic Information And Sales Area

Table 54: Sanofi. Products Portfolio

Table 55: Merck Basic Information And Sales Area

Table 56: Merck. Products Portfolio

Table 57: Pfizer Basic Information And Sales Area

Table 58: Pfizer. Products Portfolio

Table 59: Jintan Basic Information And Sales Area

Table 60: Jintan. Products Portfolio

Table 61: CSL Basic Information And Sales Area

Table 62: CSL. Products Portfolio

Table 63: MedImmune LLC Basic Information And Sales Area

Table 64: MedImmune LLC. Products Portfolio

Table 65: J&J(Crucell) Basic Information And Sales Area

Table 66: J&J(Crucell). Products Portfolio

Table 67: China National Biotec Basic Information And Sales Area

Table 68: China National Biotec. Products Portfolio

Table 69: Tiantan Basic Information And Sales Area

Table 70: Tiantan. Products Portfolio

Table 71: Hualan Basic Information And Sales Area

Table 72: Hualan. Products Portfolio

Table 73: Kangtai Basic Information And Sales Area

Table 74: Kangtai. Products Portfolio

Table 75: Hissen Basic Information And Sales Area

Table 76: Hissen. Products Portfolio

Table 77: Global Market Value (USD Million) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Value (USD Million) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Market Volume (K) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Volume (K) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Travel Vaccines Market Value (USD Million) By Region

Table 86: Global Travel Vaccines Market Share (%) By Region (2025-2032)

Table 87: North America Market Value (USD Million) (2025-2032) By Country

Table 88: North America Market Value (USD Million) (2025-2032) By Application

Table 89: North America Market Value (USD Million) (2025-2032) By Types

Table 90: Europe Market Value (USD Million) (2025-2032) By Country

Table 91: Europe Market Value (USD Million) (2025-2032) By Application

Table 92: Europe Market Value (USD Million) (2025-2032) By Types

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 94: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 96: South America Market Value (USD Million) (2025-2032) By Country

Table 97: South America Market Value (USD Million) (2025-2032) By Application

Table 98: South America Market Value (USD Million) (2025-2032) By Types

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 100: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 102: Global Travel Vaccines Market Volume (K) By Region

Table 103: Global Travel Vaccines Market Share (%) By Region (2025-2032)

Table 104: North America Market Volume (K) (2025-2032) By Country

Table 105: North America Market Volume (K) (2025-2032) By Application

Table 106: North America Market Volume (K) (2025-2032) By Types

Table 107: Europe Market Volume (K) (2025-2032) By Country

Table 108: Europe Market Volume (K) (2025-2032) By Application

Table 109: Europe Market Volume (K) (2025-2032) By Types

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 111: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 113: South America Market Volume (K) (2025-2032) By Country

Table 114: South America Market Volume (K) (2025-2032) By Application

Table 115: South America Market Volume (K) (2025-2032) By Types

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 117: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 119: Research Programs/Design For This Report

Table 120: Key Data Information From Secondary Sources

Table 121: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Travel Vaccines Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.60 million
Revenue forecast in 2033	22.98 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GSK; Sanofi; Merck; Pfizer; Jintan; CSL; MedImmune LLC; J&J(Crucell); China National Biotec; Tiantan; Hualan; Kangtai; Hissen
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options